Aberant Gene Expression Prostate Carcinoma - NCT00868803-01805 (Clinical Trial 280342)


Welcome To Clinical Connection



Our clinical trials database is updated daily
Over 250,000 individuals are currently being connected to clinical trials by ClinicalConnection.com!


Trials Alerts	Trials Search
Health Forum	Health News
RSS	Intro
Clinics & Sponsors	Member Login

View Clinical Trial (Medical Research Study)

Aberant Gene Expression Prostate Carcinoma - NCT00868803-01805 (Clinical Trial 280342)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy280342.aspx

** Please review additional "Nearby Studies" on right ----->

City:

Burlington

State:

Zip Code:

01805

Conditions:

Prostate Cancer

Purpose:

The goal of the study is to gain a better understanding of the molecular changes responsible for causing prostate cancer and that examination of tissue and blood samples will help in the development of improved screening and therapeutic approaches.

Study summary:

The goal of this study is to identify novel genetic elements that are aberantly expressed throughout prostatic neoplastic progression. The approaches proposed exploit the known familial arm of prostatic cancer, using established molecular genetic approaches, and extend these studies to sporadic prostatic cancer using a novel technique of differential display. Application of the latter technique to colon cancer in the American population establishes this tumor type as a high priority for scientific investigation and this study is part of an initiative to address this problem. Presently the studies in the field of prostate are under-represented. The collection of tissue samples from patients diagnosed with prostate cancer. Patients will also provide a blood sample at the time of their surgery and potentially post-op from 6 mos to 5 years. Samples will also be obtained from patients who's biopsy turns out to be non-prostate cancer. These samples will be obtained shortly following the biopsy out to 6 months after the biopsy.

Criteria:

Inclusion Criteria: - Diagnosed prostate cancer undergoing prostatectomy - Suspicion of prostate cancer undergoing biopsy - negative biopsy - Health volunteer (control group) - blood sample for PSA Exclusion Criteria: - Patients not fitting the inclusion criteria

Study is available at:

Lahey Clinic
Burlington, MA 01805
United States

Primary Contact:
JohN A Libertino, M.D.
Email: John.A.Libertino@Lahey.org
Phone: 781-744-2511

Secondary Contact:
John A Libertino, M.D.
Email: John.A.Libertino@Lahey.org
Phone: 781-744

If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.

Trials Alerts:

If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source:		ClinicalTrials.gov
Date Processed:		February 17, 2010
Modifications to this listing:		Only selected fields are shown, please use the link above to view all information about this clinical trial.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.


Featured Nearby Studies:

Within 25 Miles

Elderly Insomnia - Belmont MA

Restless Legs Syndrome (RLS) - Brighton MA

Myelodysplastic Syndrome (MDS) (Market Research) - NATIONWIDE

Diabetic Gastroparesis - Boston MA

Diabetic Gastroparesis - Boston MA

Restless Legs Syndrome - Newton MA

Bacterial Vaginosis - Haverhill MA

Major Depressive Disorder (MDD) - Braintree MA

Within 50 Miles

Depression - Providence RI

Within 100 Miles


Clinical Trials Search

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted nationwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.